Summary and Info
With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency. • Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition• Tackles a problem that adds billions of dollars to drug development programs and health care costs• Guides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can fail• Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition
More About the Author
Alex is a common given name commonly associated with the Greek name Alexandros. In English, it is usually a diminutive of the male given name Alexander, or its female equivalent Alexandra or Alexandria.
Review and Comments
Rate the Book
Attrition in the pharmaceutical industry : reasons, implications, and pathways forward 0 out of 5 stars based on 0 ratings.